MarketPulse

targeted therapies

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Peripheral T-Cell Lymphoma Market Set to Expand 7% Annually Through 2036

PTCL market valued at USD 800 million in 2025 to grow 7% annually through 2036, driven by emerging therapies and rising disease incidence. U.S. represents 68% of market.
BMYCELGrMRKPFEIPHA+3FDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

90+ Companies Racing to Transform Psoriasis Treatment Landscape

Over 90 pharmaceutical companies are advancing 100+ psoriasis drugs through clinical trials, with major players like Takeda and Alumis posting positive Phase III results.
SNGXTAKFBLGCANFALMS+1clinical trialsbiologics
BenzingaBenzinga··Globe Newswire

Servier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline

Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.
DAWNacquisitionbiopharmaceutical